Shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) have earned an average rating of “Moderate Buy” from the six ratings firms that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average […]
Shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) were up 8.8% during mid-day trading on Tuesday . The company traded as high as $6.22 and last traded at $6.20. Approximately 930,129 shares changed hands during trading, a decline of 41% from the average daily volume of 1,573,280 shares. The stock had previously closed […]
Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the six brokerages that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month price target among brokerages […]
Shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the six ratings firms that are currently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The […]
Shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $5.87 and traded as low as $4.30. Cogent Biosciences shares last traded at $4.38, with a volume of 1,172,921 shares traded. Analysts Set New Price Targets […]